The PE Ratio as of December 2024 (TTM) for BiondVax Pharmaceuticals Ltd. (BVXV) is -0.58

According to BiondVax Pharmaceuticals Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.58. This represents a change of -100.00% compared to the average of 24.92K of the last 4 quarters.

BiondVax Pharmaceuticals Ltd. (BVXV) Historical PE Ratio (quarterly & annually)

How has BVXV PE Ratio performed in the past?

The mean historical PE Ratio of BiondVax Pharmaceuticals Ltd. over the last ten years is -420353.56. The current -0.58 PE Ratio has changed -99.99% with respect to the historical average. Over the past ten years (40 quarters), BVXV's PE Ratio was at its highest in in the December 2022 quarter at 99.70K. The PE Ratio was at its lowest in in the December 2016 quarter at -716.03.

BiondVax Pharmaceuticals Ltd. (BVXV) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BiondVax Pharmaceuticals Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BiondVax Pharmaceuticals Ltd. (BVXV) Average PE Ratio

How has BVXV PE Ratio performed in the past?

The current PE Ratio of BiondVax Pharmaceuticals Ltd. (BVXV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BiondVax Pharmaceuticals Ltd. (BVXV) PE Ratio vs. Peers

How is BVXV’s PE Ratio compared to its peers?

BiondVax Pharmaceuticals Ltd.’s PE Ratio is less than First Wave BioPharma, Inc. (-0.29), less than Salarius Pharmaceuticals, Inc. (-0.38), greater than SAB Biotherapeutics, Inc. (-0.83), less than Vaccinex, Inc. (-0.13), greater than GeoVax Labs, Inc. (-0.60), greater than Molecular Partners AG (-2.46), greater than Mineralys Therapeutics, Inc. (-4.16), greater than AN2 Therapeutics, Inc. (-0.67), greater than Pharvaris N.V. (-7.35), greater than PepGen Inc. (-1.51), greater than Can-Fite BioPharma Ltd. (-1.52), less than Oramed Pharmaceuticals Inc. (21.80), greater than MediWound Ltd. (-6.70), greater than BioLineRx Ltd. (-1.04), greater than Surrozen, Inc. (-0.89), greater than Armata Pharmaceuticals, Inc. (-1.78), less than Pasithea Therapeutics Corp. (-0.17), less than Oncternal Therapeutics, Inc. (-0.05), less than Aditxt, Inc. (-0.00), less than Adial Pharmaceuticals, Inc. (-0.47), greater than TransCode Therapeutics, Inc. (-3.46), greater than Reviva Pharmaceuticals Holdings, Inc. (-1.80), less than Avenue Therapeutics, Inc. (-0.20),

Build a custom stock screener for BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BiondVax Pharmaceuticals Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BiondVax Pharmaceuticals Ltd. (BVXV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BiondVax Pharmaceuticals Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.